Diligence memo · auto-generated · as of July 2, 2026

Spinal Ventures, LLC

Spinal Ventures, LLC looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Spinal Ventures, LLC operates in Biotechnology, based in CHANHASSEN.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Spinal Ventures, LLC has raised $500K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $370K on 2013-10-29.

Most recent recorded round closed around 2013-10-29.

Valuation (modeled)modeled

Provath models Spinal Ventures, LLC at approximately $20M (range $197K–$232M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.29× the median modeled value of Pre-Seed Biotechnology companies in 2013–2015 (131 peers) — value vs value, same stage and era. Within the normal band (129% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 38 months.

Last raise 12.7 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 2.8× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 11% of Biotechnology peers (4293 compared).

Modeled value ranks above 29% of those peers.

Closest niche peers: Imanis Life Sciences, LLC, Truminim, LLC, Direct Spinal Therapeutics, Inc., Universal Biosensors Inc, One World Lab, Inc..

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.